Dr. Roderick M. Quiros

Alexander Shifrin, MD, is an endocrine surgeon with Atlantic Medical Group Surgical Associates of CentraState and surgical director, CentraState Endocrine Program. He is board-certified in surgery by the American Board of Surgery, and in endocrine neck ultrasound and ultrasound-guided thyroid biopsy by the American College of Endocrinology. In addition, he is the first endocrine surgeon in the United States to have board certification in endocrine surgery (FEBS), a designation available only through the European Board of Surgery. He completed two fellowship training programs: one in trauma and surgical critical care, and a second in endocrine surgery.A national and international leader in the management of complex endocrine diseases, Dr. Shifrin has specific expertise in minimally invasive surgical procedures to treat endocrine cancers and diseases of the thyroid, parathyroid, and adrenal glands. These include thyroid gland diseases such as: thyroid cancer, multinodular goiter, Graves’ disease; parathyroid gland diseases such as: primary hyperparathyroidism, secondary and tertiary hyperparathyroidism; adrenal gland diseases such as: Cushing’s syndrome, primary hyperaldosteronism (Conn’s syndrome), pheochromocytoma, and adrenal incidentaloma; familial endocrine syndromes; and other hereditary endocrine syndromes. Utilizing an evidence-based approach, Dr. Shifrin employs state-of-the-art techniques to perform hundreds of surgeries each year with precision, accuracy, and extremely high success rates. He works in collaboration with other specialists to provide patients leading-edge cancer treatments in a safe environment. He is a Fellow of the American College of Surgeons (FACS), Fellow of the American College of Endocrinology (FACE), and Fellow of the International Society of Surgery (FISS).Dr. Shifrin has edited and authored several books and atlases, including the Atlas of Thyroid Surgery, Atlas of Parathyroid Surgery, Atlas of Adrenal Surgery, Atlas of Parathyroid Imaging and Pathology, Endocrine Emergencies, Advances in Treatment and Management in Surgical Endocrinology, and Endocrine Surgery Comprehensive Board Exam Guide, book chapters, and peer-reviewed papers. He is also a frequent speaker at national and international conferences.Dr. Shifrin pursued extensive surgery residency training at the Hospital of the University of Pennsylvania, followed by Penn State Milton S. Hershey Medical Center. Dr. Shifrin is a full Professor of Surgery at Hackensack Meridian School of Medicine and Clinical Associate Professor of Surgery at Rutgers Robert Wood Johnson Medical School. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shifrin is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Parathyroid Hyperplasia, Familial Isolated Hyperparathyroidism, Hyperparathyroidism, and Neonatal Severe Hyperparathyroidism.

Douglas Fraker is a General Surgeon and a Surgical Oncologist in Radnor, Pennsylvania. Dr. Fraker is rated as an Elite provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Hyperparathyroidism, Zollinger-Ellison Syndrome, Neuroendocrine Tumor, Parathyroidectomy, and Thyroidectomy. Dr. Fraker is currently accepting new patients.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.